23 hrs ago | MarketWatch
InBev, Busch uncle, aim to oust Anheuser-Busch board
Belgian brewer InBev on Monday announced its latest move in its quest to buy Anheuser-Busch, putting up an alternative slate of directors that includes a descendant of the founding Busch family.
Monday | Motley Fool
Once a pharma gets its first drug approved, one of the hardest things to do is to capture the spoils.
IDEM probes release of PCBs from wastewater lagoon
State and federal environmental officials are trying to determine if the release of toxins from a wastewater lagoon at a Pfizer Inc.
Flint Township/Swartz Creek Advance
Pfizer gets FDA approval for new one-dose antibiotic for dogs and cats
The federal government has approved a new Pfizer Inc. antibiotic for dogs and cats that next year will be manufactured in Portage.
Pfizer By American Technology Research WE ARE INITIATING COVERAGE of Pfizer with a Buy rating.
Pfizer suit can go on, judge rules
A class-action lawsuit filed by the $15.2 billion Louisiana Teachers' Retirement System, Baton Rouge, as lead plaintiff against Pfizer Inc., New York, can go forward, but without parts of the original suit, a ...
No prison time for Pfizer employee embezzlement
APNewsNow. Moving on general news and financial services. NEW LONDON, Conn. _ A former executive assistant at Pfizer Inc.
Pfizer Changes Its Funding of Continuing Medical Education in the U.S.
Pfizer today announced changes in the way it supports continuing medical education initiatives for U.S. healthcare professionals.
FDA approves antibiotic for cats, dogs
The FDA has approved a single-dose antibiotic from Pfizer Inc. for cats and dogs, shortening treatment from two weeks to one day.
Bristol-Myers Could Be An Acquisition Target: Bernstein
Drugmaker Bristol-Myers Squibb Co could be an acquisition target as the industry gets closer to losing exclusivity on several leading drugs, said a Sanford C. Bernstein analyst, who upgraded the stock to ...
Pfizer Cuts Off Funding for Medical Education Companies
In a move certain to spark great controversy in the continuing medical education community, pharmaceutical giant Pfizer announced on July 2 that it will no longer award grants to medical education companies.
FDA Approves First And Only Single-Dose Antibiotic For Dogs And Cats
Main Category: Veterinary Also Included In: Regulatory Affairs / Drug Approvals Article Date: 02 Jul 2008 - 2:00 PDT Pfizer Animal Health has announced the Food and Drug Administration has approved Convenia , ...
Pfizer second-quarter net profit at Rs 38 cr
Tuesday , July 01, 2008 at 2217 hrs Pfizer Ltd, the Indian arm of US pharmaceutical giant Pfizer Inc, on Monday said that the company posted a net profit for its fiscal second quarter of Rs 37.92 crore.
Drug Industry Wooed Politicians with Record $168M Last Year
The drug industry continued its reign as the top Capitol Hill lobbying group, with a record $168 million in contributions for 2007, a nonpartisan Washington watchdog reported.
Isis Pharmaceuticals' Obesity Buster an Enormous Finding
Logic may dictate that Isis Pharmaceuticals' largest multibillion-dollar blockbuster drug is its anti-lipid drug Mipomersen.
Further to the demise of Pfizer's chief patent person, Alan Hesketh, over child pornography, the pharma log blog has some other items in a post, Rumors, innuendo, criminal charges and changes inside Pfizer ...
Startup targets security, performance of Web applications
Start-up Sonoa Systems is coming out of stealth mode with a product that improves the security and performance of Web applications in a service-oriented architecture environment.
EyeCyte, Inc. Secures Series A Funding From Pfizer
EyeCyte, Inc., an early stage stem/progenitor cell-based ophthalmology research and development company based in La Jolla, California, announced that it has secured its Series A funding through an agreement ...
Pfizer Invites Public to View and Listen to Webcast of July 23 Conference Call with Analysts
Pfizer Inc invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 11 a.m. Eastern Daylight Saving Time on Wednesday, July 23.
Melior signs option agreement with Pfizer
Exton, June 25: Melior Discovery, Inc. announced that it has signed an option agreement that provides Pfizer Inc the exclusive right to negotiate a license to MLR-1023, Melior's drug candidate for Type II ...